Drug Shortage Report for RAN-CITALO

Last updated on 2020-03-07 History
Report ID 105121
Drug Identification Number 02285622
Brand name RAN-CITALO
Common or Proper name CITALO
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Market Status MARKETED
Active Ingredient(s) CITALOPRAM
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-31
Estimated end date 2020-06-30
Actual end date 2020-02-28
Shortage status Resolved
Updated date 2020-03-07
Company comments
Health Canada comments
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-03-07 French Compare
v3 2020-03-07 English Compare
v2 2020-02-02 French Compare
v1 2020-02-02 English Compare